Neoadjuvant immunotherapy may be setting a new standard in the treatment of certain cancers, including stage III melanoma. However, reports also mention its potential use and approval in other types of cancer, such as colon, gastric, and gastroesophageal cancers, suggesting its application may be broader. The role of neoadjuvant immunotherapy in various cancer treatments appears to be an area of ongoing discussion and development.